Announced
Synopsis
Strides Pharma Science, an Indian pharmaceutical company, is set to demerge its contract development and manufacturing organisation into an independent and publicly-traded company. “We expect this company to be formed through the NCLT process in the next 12 to 18 months considering that there are multiple companies being merged and demerged into the structure," Arun Kumar, Strides Pharma Executive Chairperson and Managing Director.
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.